全文获取类型
收费全文 | 7245篇 |
免费 | 457篇 |
国内免费 | 129篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 15篇 |
妇产科学 | 16篇 |
基础医学 | 74篇 |
口腔科学 | 22篇 |
临床医学 | 331篇 |
内科学 | 244篇 |
皮肤病学 | 12篇 |
神经病学 | 42篇 |
特种医学 | 114篇 |
外科学 | 283篇 |
综合类 | 1393篇 |
预防医学 | 418篇 |
眼科学 | 39篇 |
药学 | 3037篇 |
2篇 | |
中国医学 | 1683篇 |
肿瘤学 | 53篇 |
出版年
2024年 | 50篇 |
2023年 | 149篇 |
2022年 | 162篇 |
2021年 | 252篇 |
2020年 | 263篇 |
2019年 | 314篇 |
2018年 | 311篇 |
2017年 | 326篇 |
2016年 | 329篇 |
2015年 | 246篇 |
2014年 | 562篇 |
2013年 | 509篇 |
2012年 | 574篇 |
2011年 | 562篇 |
2010年 | 448篇 |
2009年 | 379篇 |
2008年 | 342篇 |
2007年 | 328篇 |
2006年 | 337篇 |
2005年 | 232篇 |
2004年 | 219篇 |
2003年 | 214篇 |
2002年 | 116篇 |
2001年 | 129篇 |
2000年 | 84篇 |
1999年 | 82篇 |
1998年 | 67篇 |
1997年 | 39篇 |
1996年 | 46篇 |
1995年 | 27篇 |
1994年 | 25篇 |
1993年 | 21篇 |
1992年 | 15篇 |
1991年 | 9篇 |
1990年 | 6篇 |
1989年 | 6篇 |
1988年 | 2篇 |
1987年 | 8篇 |
1986年 | 5篇 |
1985年 | 4篇 |
1984年 | 3篇 |
1983年 | 5篇 |
1982年 | 2篇 |
1981年 | 3篇 |
1975年 | 2篇 |
1974年 | 4篇 |
1973年 | 4篇 |
1972年 | 3篇 |
1969年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有7831条查询结果,搜索用时 218 毫秒
61.
验证救心复脉注射液治疗心源性休克的临床疗效。方法:用CA静脉给药治疗心源性休克20例,用多巴胺注射液作对照。结果;CA组有效18例,无效2例,DA组有效9例,无效2例,组间比较,P〉0.05。结论CA和DA均能升高血压,增加心泵功能,改善厥脱证的症脉,但CA比DA升压速度快,幅度高,作用稳定,对心率有双相调节作用,使心动过速患者心率减慢,使心动过缓患者心率增快。 相似文献
62.
参麦注射液治疗无症状性冠心病的疗效观察 总被引:2,自引:0,他引:2
参麦注射液是由人参、麦冬中药复方提取精制而成的注射液。临床观察治疗无症状性冠心病26例,结果表明,参麦注射液能明显改善无症状性冠心病的ST-T改变,其作用优于对照药物消心痛,诊疗期间未见毒副作用。 相似文献
63.
64.
目的 建立醋酸亮丙瑞林注射液中亮丙瑞林及杂质的测定方法。方法 采用高效液相色谱法。色谱柱 :Kromasil C18-ODS(150mm×4.6mm ,5 μm)不锈钢柱 ;流动相 :水相 (800ml水 +21ml三乙胺 ,磷酸调pH 3.0 ,加水至 1000ml)-有机相 (正丙醇-乙腈 =2∶3)为 84∶16 ;检测波长:220nm ;含量测定采用外标法 ,杂质检查采用自身对照法。结果 在优化的色谱条件下 ,亮丙瑞林及杂质间均能完全分离 ,注射液辅料不干扰测定 ,亮丙瑞林线性范围 9.198~ 82.780 μg·ml-1,检测限 1.93ng(S/N =3) ,含量测定的回收率 98.74%~100.3% ,RSD<1.5%。结论 该法专属性强,操作方便 ,结果准确 ,重现性好。 相似文献
65.
氟罗沙星注射液的稳定性研究 总被引:5,自引:0,他引:5
目的 :考察氟罗沙星注射液的稳定性。方法 :采用高效液相色谱法测定氟罗沙星注射液中氟罗沙星及其降解产物的含量 ,并考察光照、加热、pH值及卤族元素离子对其稳定性的影响。结果 :氟罗沙星平均回收率为100.4 % (RSD=0. 87 % ) ;若pH值偏低、光照或加热时间较长 ,氟罗沙星注射液色泽则明显加深 ,降解产物含量增加 ;遇卤族元素离子则析出沉淀。结论 :氟罗沙星注射液对光、热不稳定 ,容易分解 ,对光尤为明显 ;pH值越低 ,越易降解 ;不宜与含卤族元素离子的药物配伍使用。 相似文献
66.
67.
Does the Impact of Managed Care on Substance Abuse Treatment Services Vary by Provider Profit Status? 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Health services research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Objective. To extend our previous research by determining whether, and how, the impact of managed care (MC) on substance abuse treatment (SAT) services differs by facility ownership.
Data Sources. The 2000 National Survey of Substance Abuse Treatment Services, which is designed to collect data on service offerings and other characteristics of SAT facilities in the U.S. These data are merged with data from the 2002 Area Resource File, a county-specific database containing information on population and MC activity. We use data on 10,513 facilities, virtually a census of all SAT facilities.
Study Design. For each facility ownership type (for-profit [FP], not-for-profit [NFP], public), we estimate the impact of MC on the number and types of SAT services offered. We use instrumental variables techniques that account for possible endogeneity between facilities' involvement in MC and service offerings.
We find that the impact of MC on SAT service offerings differs in magnitude and direction by facility ownership. On average, MC causes FPs to offer approximately four additional services, causes publics to offer approximately four fewer services, and has no impact on the number of services offered by NFPs. The differential impact of MC on FPs and publics appears to be concentrated in therapy/counseling, medical testing, and transitional services.
Conclusion. Our findings raise policy concerns that MC may reduce the quality of care provided by public SAT facilities by limiting the range of services offered. On the other hand, we find that FP clinics increase their range of services. One explanation is that MC results in standardization of service offerings across facilities of different ownership type. Further research is needed to better understand both the specific mechanisms of MC on SAT and the net impact on society. 相似文献
Data Sources. The 2000 National Survey of Substance Abuse Treatment Services, which is designed to collect data on service offerings and other characteristics of SAT facilities in the U.S. These data are merged with data from the 2002 Area Resource File, a county-specific database containing information on population and MC activity. We use data on 10,513 facilities, virtually a census of all SAT facilities.
Study Design. For each facility ownership type (for-profit [FP], not-for-profit [NFP], public), we estimate the impact of MC on the number and types of SAT services offered. We use instrumental variables techniques that account for possible endogeneity between facilities' involvement in MC and service offerings.
Principal Findings.
We find that the impact of MC on SAT service offerings differs in magnitude and direction by facility ownership. On average, MC causes FPs to offer approximately four additional services, causes publics to offer approximately four fewer services, and has no impact on the number of services offered by NFPs. The differential impact of MC on FPs and publics appears to be concentrated in therapy/counseling, medical testing, and transitional services.
Conclusion. Our findings raise policy concerns that MC may reduce the quality of care provided by public SAT facilities by limiting the range of services offered. On the other hand, we find that FP clinics increase their range of services. One explanation is that MC results in standardization of service offerings across facilities of different ownership type. Further research is needed to better understand both the specific mechanisms of MC on SAT and the net impact on society. 相似文献
68.
69.
70.
血塞通注射液对糖尿病视网膜病变临床前期血栓素B2及6-酮-前列腺素F1α的干预作用 总被引:1,自引:0,他引:1
刘莹 《中国中医药信息杂志》2005,12(1):23-23,56
目的观察血塞通注射液对糖尿病视网膜病变临床前期的干预作用及疗效评价.方法将符合诊断标准的6 3例糖尿病性视网膜病变临床前期患者随机分为观察组(44例)和对照组(41例).观察组给予血塞通注射液,对照组不予任何处理.观察治疗前后的血栓素B2(TXB2)及6-酮-前列腺素F1α(6-keto-PGF1α)的含量变化、评价疗效.结果与对照组比较,血塞通注射液能显著下调TXB2含量(P<0.01),上调6-keto-PGF1α含量(P<0.01),ARR=100.0%、RR=0、RRR=100.0%、NNT=1(例).结论血塞通注射液能显著干预和阻止糖尿病性视网膜病变;疗效评价显示治疗效果好,临床价值大. 相似文献